Outlook Therapeutics (OTLK) Shareholder's Equity Growth (5y) (2020 - 2026)
Outlook Therapeutics (OTLK) Shareholder's Equity Growth (5y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Outlook Therapeutics |
51.56 Mn |
43.81 Mn |
-21,888.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-27.76% |
| Dec 31, 2025 |
-29.77% |
| Sep 30, 2025 |
-68.01% |
| Jun 30, 2025 |
-40.07% |
| Mar 31, 2025 |
-9.60% |
| Dec 31, 2024 |
-10.21% |
| Sep 30, 2024 |
-35.28% |
| Jun 30, 2024 |
-66.42% |
| Mar 31, 2024 |
-36.73% |
| Dec 31, 2023 |
1.57% |
| Sep 30, 2023 |
10.78% |
| Jun 30, 2023 |
16.05% |
| Mar 31, 2023 |
18.25% |
| Dec 31, 2022 |
21.32% |
| Sep 30, 2022 |
17.71% |
| Jun 30, 2022 |
21.92% |
| Mar 31, 2022 |
27.27% |
| Dec 31, 2021 |
33.47% |
| Sep 30, 2021 |
23.65% |
| Jun 30, 2021 |
52.16% |
